The Impact of COVID-19 is included in Japanese Encephalitis Vaccine Market Report. Buy it today to get an advantage.
Request the impact of COVID-19 on your product or industry
Japanese Encephalitis Vaccine Trends and Forecast
The future of the global japanese encephalitis vaccine market looks promising with opportunities in the hospital, retail, and online markets. The global japanese encephalitis vaccine market is expected to reach an estimated $0.3 billion by 2030 with a CAGR of 5.8% from 2024 to 2030. The major drivers for this market are growing cases of japanese encephalitis, increasing demand for oral drugs, and irising risk of exposure to japanese encephalitis given to urbanization.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Japanese Encephalitis Vaccine by Segment
The study includes a forecast for the global japanese encephalitis vaccine by type, distribution channel, application, and region.
Japanese Encephalitis Vaccine Market by Type [Shipment Analysis by Value from 2018 to 2030]:
• Inactivated
• Recombinant
• Live Attenuated
Japanese Encephalitis Vaccine Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:
• Hospitals
• Retail
• Online
Japanese Encephalitis Vaccine Market by Application [Shipment Analysis by Value from 2018 to 2030]:
• Pediatric Vaccines
• Adult Vaccines
Japanese Encephalitis Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:
• North America
• Europe
• Asia Pacific
• The Rest of the World
List of Japanese Encephalitis Vaccine Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies japanese encephalitis vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the japanese encephalitis vaccine companies profiled in this report include-
• Valneva
• Sanofi
• Bharat Biotech International
• Chengdu Institute of Biological Products
• Adimmune
Japanese Encephalitis Vaccine Market Insights
Lucintel forecasts that live attenuated will remain the largest segment due to its effectiveness and inducing a strong immune response to the body.
Within this market, hospital is expected to witness highest growth over the forecast period.
APAC will remain the largest regiondue to rising risk of japanese encephalitis in India, China, and Japan.
Features of the Global Japanese Encephalitis Vaccine Market
Market Size Estimates: Japanese encephalitis vaccine market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Japanese encephalitis vaccine market size by type, distribution channel, application, and region in terms of value ($B).
Regional Analysis: Japanese encephalitis vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different types, distribution channels, applications, and regions for the japanese encephalitis vaccine market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the japanese encephalitis vaccine market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q.1 What is the japanese encephalitis vaccine market size?
Answer: The global japanese encephalitis vaccine market is expected to reach an estimated $0.3 billion by 2030.
Q.2 What is the growth forecast for japanese encephalitis vaccine market?
Answer: The global japanese encephalitis vaccine market is expected to grow with a CAGR of 5.8% from 2024 to 2030.
Q.3 What are the major drivers influencing the growth of the japanese encephalitis vaccine market?
Answer: The major drivers for this market are growing cases of japanese encephalitis, increasing demand for oral drugs and irising risk of exposure to japanese encephalitis given to urbanization.
Q4. What are the major segments for japanese encephalitis vaccine market?
Answer: The future of the japanese encephalitis vaccine market looks promising with opportunities in the hospital, retail, and online markets.
Q5. Who are the key japanese encephalitis vaccine market companies?
Answer: Some of the key japanese encephalitis vaccine companies are as follows:
• Valneva
• Sanofi
• Bharat Biotech International
• Chengdu Institute of Biological Products
• Adimmune
Q6. Which japanese encephalitis vaccine market segment will be the largest in future?
Answer: Lucintel forecasts that live attenuated will remain the largest segment due to its effectiveness and inducing a strong immune response to the body.
Q7. In japanese encephalitis vaccine market, which region is expected to be the largest in next 5 years?
Answer: APAC will remain the largest regiondue to rising risk of japanese encephalitis in India, China, and Japan.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the japanese encephalitis vaccine market by type (inactivated, recombinant, and live attenuated), distribution channel (hospitals, retail, and online), application (pediatric vaccines and adult vaccines), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Japanese Encephalitis Vaccine Market, Japanese Encephalitis Vaccine Market Size, Japanese Encephalitis Vaccine Market Growth, Japanese Encephalitis Vaccine Market Analysis, Japanese Encephalitis Vaccine Market Report, Japanese Encephalitis Vaccine Market Share, Japanese Encephalitis Vaccine Market Trends, Japanese Encephalitis Vaccine Market Forecast, Japanese Encephalitis Vaccine Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.
Table of Contents
1. Executive Summary
2. Global Japanese Encephalitis Vaccine Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Japanese Encephalitis Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Japanese Encephalitis Vaccine Market by Type
3.3.1: Inactivated
3.3.2: Recombinant
3.3.3: Live Attenuated
3.4: Global Japanese Encephalitis Vaccine Market by Distribution Channel
3.4.1: Hospitals
3.4.2: Retail
3.4.3: Online
3.5: Global Japanese Encephalitis Vaccine Market by Application
3.5.1: Pediatric Vaccines
3.5.2: Adult Vaccines
4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Japanese Encephalitis Vaccine Market by Region
4.2: North American Japanese Encephalitis Vaccine Market
4.2.2: North American Japanese Encephalitis Vaccine Market by Distribution Channel: Hospitals, Retail, and Online
4.3: European Japanese Encephalitis Vaccine Market
4.3.1: European Japanese Encephalitis Vaccine Market by Type: Inactivated, Recombinant, and Live Attenuated
4.3.2: European Japanese Encephalitis Vaccine Market by Distribution Channel: Hospitals, Retail, and Online
4.4: APAC Japanese Encephalitis Vaccine Market
4.4.1: APAC Japanese Encephalitis Vaccine Market by Type: Inactivated, Recombinant, and Live Attenuated
4.4.2: APAC Japanese Encephalitis Vaccine Market by Distribution Channel: Hospitals, Retail, and Online
4.5: ROW Japanese Encephalitis Vaccine Market
4.5.1: ROW Japanese Encephalitis Vaccine Market by Type: Inactivated, Recombinant, and Live Attenuated
4.5.2: ROW Japanese Encephalitis Vaccine Market by Distribution Channel: Hospitals, Retail, and Online
5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Japanese Encephalitis Vaccine Market by Type
6.1.2: Growth Opportunities for the Global Japanese Encephalitis Vaccine Market by Distribution Channel
6.1.3: Growth Opportunities for the Global Japanese Encephalitis Vaccine Market by Application
6.1.4: Growth Opportunities for the Global Japanese Encephalitis Vaccine Market by Region
6.2: Emerging Trends in the Global Japanese Encephalitis Vaccine Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Japanese Encephalitis Vaccine Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Japanese Encephalitis Vaccine Market
6.3.4: Certification and Licensing
7. Company Profiles of Leading Players
7.1: Valneva
7.2: Sanofi
7.3: Bharat Biotech International
7.4: Chengdu Institute of Biological Products
7.5: Adimmune
.
Buy full report or by chapter as follows
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
In-depth interviews of the major players in this market
Detailed secondary research from competitors’ financial statements and published data
Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Please sign in below to get report brochure - Japanese Encephalitis Vaccine Market Report.